High Tower Advisors, LLC Nektar Therapeutics Call Options Transaction History

High Tower Advisors, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2020 Aug 10, 2020	SELL	$16.86 - $23.44 $3,372 - $4,688	-200 Reduced 66.67%	100 $0
Q3 2019 Nov 12, 2019	SELL	$16.91 - $36.27 $13,528 - $29,016	-800 Reduced 72.73%	300 $1,000
Q2 2019 Aug 13, 2019	SELL	$31.0 - $36.3 $114,700 - $134,310	-3,700 Reduced 77.08%	1,100 $13,000
Q1 2019 May 15, 2019	BUY	$31.58 - $46.35 $113,688 - $166,860	3,600 Added 300.0%	4,800 $2,000
Q2 2018 Aug 14, 2018	BUY	$46.25 - $104.45 $32,375 - $73,115	700 Added 140.0%	1,200 $2,000

Q4 2017 Feb 14, 2018	SELL	$23.02 - $60.5 $25,322 - $66,550	-1,100 Reduced 68.75%	500 $4,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,600	1,600 $9,000

128

111M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $231M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.